Bioventus Inc. (BVS)
- Sector
- Health Care
- Last price
- $10.61
- As of
Kresmion compiles this page from BVS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Bioventus Inc. (BVS): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-02.
See the full BVS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BVS on one page. Preview it with sample data, then open it live with a free account.
Preview the BVS dossierActive events for BVS
- mediumEarnings above estimates
Q3-2026: Beat consensus by 5.2%, EPS $0.17 vs $0.1616 estimate
- high13F: funds added
4 tracked funds increased BVS this 2026Q2, institutional consensus
- mediumTrend spike
Bioventus Inc. search volume spiked +100 pts, unusual interest
- high13F: large reduction
CITADEL ADVISORS LLC cut 56% of BVS (2026Q2)
- high13F: funds added
3 tracked funds increased BVS this 2026Q2, institutional consensus
FREE, NO ACCOUNT
Every event on BVS, as it fires
You are seeing 5 of 13 events recorded on BVS since 2026-05-31.
The five above landed across 4 days. The other 8 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
BVS positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 09075A108 · 2026Q2 | $6.9M | 0.01% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 09075A108 · 2026Q2 | $2.2M | 0.00% |
| MILLENNIUM MANAGEMENT LLC FundCUSIP 09075A108 · 2026Q2 | $1.9M | 0.00% |
| Point72 Asset Management, L.P. FundCUSIP 09075A108 · 2026Q2 | $1.6M | 0.00% |
| D. E. Shaw & Co., Inc. FundCUSIP 09075A108 · 2026Q2 | $447K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, BVS
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
More data on BVS
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BVS on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BVS in the last 180 days.
Upstream: SEC EDGAR filings for BVS
Kresmion, "Bioventus Inc. (BVS) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/BVS. Upstream data: SEC EDGAR filings for BVS.
Link to this data (HTML):
<a href="https://kresmion.com/research/BVS">Bioventus Inc. (BVS) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BVS on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BVS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.